JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

Search

Intuitive Surgical Inc

Geschlossen

BrancheGesundheitswesen

551.23 4.64

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

525.35

Max

552.26

Schlüsselkennzahlen

By Trading Economics

Einkommen

-40M

664M

Verkäufe

187M

2.4B

KGV

Branchendurchschnitt

62.123

37.461

Gewinnspanne

27.221

Angestellte

15,638

EBITDA

268M

987M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+16.06% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-21B

164B

Vorheriger Eröffnungskurs

546.59

Vorheriger Schlusskurs

551.23

Nachrichtenstimmung

By Acuity

23%

77%

127 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bearish Evidence

Intuitive Surgical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

21. Okt. 2025, 23:55 UTC

Heiße Aktien

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21. Okt. 2025, 21:14 UTC

Ergebnisse
Wichtige Markttreiber

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21. Okt. 2025, 20:38 UTC

Ergebnisse

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22. Juli 2025, 21:13 UTC

Ergebnisse

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22. Apr. 2025, 20:55 UTC

Ergebnisse

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

22. Okt. 2025, 15:42 UTC

Ergebnisse

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22. Okt. 2025, 12:34 UTC

Ergebnisse

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22. Okt. 2025, 11:49 UTC

Ergebnisse

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21. Okt. 2025, 20:08 UTC

Ergebnisse

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21. Okt. 2025, 20:08 UTC

Ergebnisse

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21. Okt. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 3Q Rev $2.51B >ISRG

21. Okt. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 3Q Net $704.4M >ISRG

21. Okt. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21. Okt. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21. Okt. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 3Q EPS $1.95 >ISRG

22. Juli 2025, 20:14 UTC

Ergebnisse

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22. Juli 2025, 20:13 UTC

Ergebnisse

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22. Juli 2025, 20:13 UTC

Ergebnisse

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q Net $658.4M >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q Rev $2.44B >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22. Juli 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 2Q EPS $1.81 >ISRG

22. Apr. 2025, 20:13 UTC

Ergebnisse

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q EPS $1.92 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Net $698.4M >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Rev $2.25B >ISRG

24. Jan. 2025, 21:17 UTC

Ergebnisse

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

Peer-Vergleich

Kursveränderung

Intuitive Surgical Inc Prognose

Kursziel

By TipRanks

16.06% Vorteil

12-Monats-Prognose

Durchschnitt 611.68 USD  16.06%

Hoch 685 USD

Tief 440 USD

Basierend auf 20 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Intuitive Surgical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

20 ratings

16

Buy

3

Halten

1

Sell

Technischer Score

By Trading Central

514.59 / 539.05Unterstützung & Widerstand

Kurzfristig

Weak Bearish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Strong Bullish Evidence

Stimmung

By Acuity

127 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat